Vault-13

TCG Crossover Management, LLC

PALO ALTO, CA · CIK 1839948 · 13F filing filed 2025-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$875.5m reported value +19.4% vs Q1 2025
38positions
56.3%in top 10
5 new 1 added 3 reduced 5 sold out vs Q1 2025

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CG ONCOLOGY INC COM CGON CGON 3,670,206 $95.4m10.90% 10.90% UnchangedShares held: Q3 2024 3.7m, Q4 2024 3.7m, Q1 2025 3.7m, Q2 2025 3.7m
2 TANGO THERAPEUTICS INC COM TNGX TNGX 10,736,000 $55.0m6.28% 6.28% UnchangedShares held: Q3 2024 0, Q4 2024 10.7m, Q1 2025 10.7m, Q2 2025 10.7m
3 COGENT BIOSCIENCES INC COM COGT COGT 6,964,375 $50.0m5.71% 5.71% UnchangedShares held: Q3 2024 7.0m, Q4 2024 7.0m, Q1 2025 7.0m, Q2 2025 7.0m
4 OCULAR THERAPEUTIX INC COM OCUL OCUL 5,319,148 $49.4m5.64% 5.64% UnchangedShares held: Q3 2024 5.3m, Q4 2024 5.3m, Q1 2025 5.3m, Q2 2025 5.3m
5 CIDARA THERAPEUTICS INC COM NEW CDTX CDTX 1,005,901 $49.0m5.60% 5.60% UnchangedShares held: Q3 2024 0, Q4 2024 1.0m, Q1 2025 1.0m, Q2 2025 1.0m
6 ABIVAX SA SPONSORED ADS ABVX ABVX 6,056,596 $46.3m5.29% 5.29% UnchangedShares held: Q3 2024 6.1m, Q4 2024 6.1m, Q1 2025 6.1m, Q2 2025 6.1m
7 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 5,943,812 $38.1m4.35% 4.35% UnchangedShares held: Q3 2024 4.6m, Q4 2024 4.6m, Q1 2025 5.9m, Q2 2025 5.9m
8 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 2,890,816 $38.0m4.34% 4.34% UnchangedShares held: Q3 2024 2.9m, Q4 2024 2.9m, Q1 2025 2.9m, Q2 2025 2.9m
9 FULCRUM THERAPEUTICS INC COM FULC FULC 5,250,000 $36.1m4.13% 4.13% UnchangedShares held: Q3 2024 5.2m, Q4 2024 5.2m, Q1 2025 5.2m, Q2 2025 5.2m
10 DYNE THERAPEUTICS INC COM DYN DYN 3,766,660 $35.9m4.10% 4.10% AddedShares held: Q3 2024 2.7m, Q4 2024 2.7m, Q1 2025 2.7m, Q2 2025 3.8m +1.1m +1,116,510 42.1%
11 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 3,572,335 $33.6m3.84% 3.84% UnchangedShares held: Q3 2024 922.3k, Q4 2024 3.6m, Q1 2025 3.6m, Q2 2025 3.6m
12 UPSTREAM BIO INC COM UPB UPB 2,801,763 $30.8m3.51% 3.51% UnchangedShares held: Q3 2024 0, Q4 2024 2.8m, Q1 2025 2.8m, Q2 2025 2.8m
13 SAVARA INC COM SVRA SVRA 12,362,205 $28.2m3.22% 3.22% UnchangedShares held: Q3 2024 12.4m, Q4 2024 12.4m, Q1 2025 12.4m, Q2 2025 12.4m
14 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 1,501,624 $28.0m3.20% 3.20% UnchangedShares held: Q3 2024 0, Q4 2024 1.5m, Q1 2025 1.5m, Q2 2025 1.5m
15 TYRA BIOSCIENCES INC COM TYRA TYRA 2,898,103 $27.7m3.17% 3.17% UnchangedShares held: Q3 2024 2.0m, Q4 2024 2.0m, Q1 2025 2.9m, Q2 2025 2.9m
16 DISC MEDICINE INC COM IRON IRON 465,257 $24.6m2.81% 2.81% UnchangedShares held: Q3 2024 487.0k, Q4 2024 487.0k, Q1 2025 465.3k, Q2 2025 465.3k
17 TOURMALINE BIO INC COM TRML TRML 1,477,593 $23.6m2.70% 2.70% UnchangedShares held: Q3 2024 1.5m, Q4 2024 1.5m, Q1 2025 1.5m, Q2 2025 1.5m
18 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 697,003 $23.2m2.65% 2.65% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 697.0k
19 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 1,063,000 $22.0m2.52% 2.52% UnchangedShares held: Q3 2024 1.1m, Q4 2024 1.1m, Q1 2025 1.1m, Q2 2025 1.1m
20 XENCOR INC COM XNCR XNCR 2,452,138 $19.3m2.20% 2.20% UnchangedShares held: Q3 2024 2.4m, Q4 2024 2.5m, Q1 2025 2.5m, Q2 2025 2.5m
21 SILENCE THERAPEUTICS PLC ADS SLN SLN 3,033,560 $17.6m2.01% 2.01% UnchangedShares held: Q3 2024 3.0m, Q4 2024 3.0m, Q1 2025 3.0m, Q2 2025 3.0m
22 SOLENO THERAPEUTICS INC COM SLNO SLNO 186,250 $15.6m1.78% 1.78% ReducedShares held: Q3 2024 550.0k, Q4 2024 550.0k, Q1 2025 275.0k, Q2 2025 186.2k -88.8k -88,750 -32.3%
23 ASTRIA THERAPEUTICS INC COM CATB CATB 2,761,861 $14.8m1.69% 1.69% UnchangedShares held: Q3 2024 2.8m, Q4 2024 2.8m, Q1 2025 2.8m, Q2 2025 2.8m
24 RAPT THERAPEUTICS INC COM NEW RAPT RAPT 1,636,275 $13.1m1.50% 1.50% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 1.6m
25 THIRD HARMONIC BIO INC COM COM 1,915,424 $10.4m1.19% 1.19% ReducedShares held: Q3 2024 2.4m, Q4 2024 2.5m, Q1 2025 2.5m, Q2 2025 1.9m -590.0k -590,000 -23.6%
26 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 498,000 $10.0m1.14% 1.14% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 498.0k
27 MBX BIOSCIENCES INC COM MBX MBX 650,000 $7.4m0.85% 0.85% UnchangedShares held: Q3 2024 650.0k, Q4 2024 650.0k, Q1 2025 650.0k, Q2 2025 650.0k
28 NEKTAR THERAPEUTICS COM NEW NKTR NKTR 266,666 $6.9m0.79% 0.79% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 266.7k
29 VISTAGEN THERAPEUTICS INC COM VTGN VTGN 2,676,580 $5.4m0.61% 0.61% UnchangedShares held: Q3 2024 2.7m, Q4 2024 2.7m, Q1 2025 2.7m, Q2 2025 2.7m
30 KODIAK SCIENCES INC COM KOD KOD 1,145,538 $4.3m0.49% 0.49% UnchangedShares held: Q3 2024 1.0m, Q4 2024 1.1m, Q1 2025 1.1m, Q2 2025 1.1m
31 KURA ONCOLOGY INC COM KURA KURA 735,184 $4.2m0.48% 0.48% ReducedShares held: Q3 2024 1.4m, Q4 2024 1.4m, Q1 2025 1.4m, Q2 2025 735.2k -688.5k -688,458 -48.4%
32 ENTRADA THERAPEUTICS INC COM TRDA TRDA 584,955 $3.9m0.45% 0.45% UnchangedShares held: Q3 2024 585.0k, Q4 2024 585.0k, Q1 2025 585.0k, Q2 2025 585.0k
33 ADVERUM BIOTECHNOLOGIES INC COM NEW ADVM ADVM 1,796,482 $3.9m0.44% 0.44% UnchangedShares held: Q3 2024 2.0m, Q4 2024 1.8m, Q1 2025 1.8m, Q2 2025 1.8m
34 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 483,000 $2.4m0.28% 0.28% UnchangedShares held: Q3 2024 483.0k, Q4 2024 483.0k, Q1 2025 483.0k, Q2 2025 483.0k
35 VENTYX BIOSCIENCES INC COM VTYX VTYX 316,195 $676.7k0.08% 0.08% UnchangedShares held: Q3 2024 316.2k, Q4 2024 316.2k, Q1 2025 316.2k, Q2 2025 316.2k
36 JADE BIOSCIENCES INC COM NEW JBIO JBIO 64,023 $639.6k0.07% 0.07% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 64.0k
37 CABALETTA BIO INC COM CABA CABA 86,795 $131.9k0.02% 0.02% UnchangedShares held: Q3 2024 86.8k, Q4 2024 86.8k, Q1 2025 86.8k, Q2 2025 86.8k
38 KEROS THERAPEUTICS INC COM KROS KROS 0 $00.00% 0.00% UnchangedShares held: Q3 2024 879.3k, Q4 2024 550.0k, Q1 2025 0, Q2 2025 0

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
MINERALYS THERAPEUTICS INC MLYS MLYS 2,470,265 $39.2m2.5m shares
RAPT THERAPEUTICS INC 13,090,200 $16.0m13.1m shares
COMPASS PATHWAYS PLC CMPS CMPS 3,858,000 $11.0m3.9m shares
AEROVATE THERAPEUTICS INC 2,240,809 $5.6m2.2m shares
NEKTAR THERAPEUTICS 4,000,000 $2.7m4.0m shares